The estimated Net Worth of Jonathan Eitan Solomon is at least $961 Tisíc dollars as of 28 July 2021. Mr. Solomon owns over 25,000 units of BiomX Inc stock worth over $24,750 and over the last 5 years he sold PHGE stock worth over $0. In addition, he makes $936,565 as Chief Executive Officer a Director at BiomX Inc.
Jonathan has made over 1 trades of the BiomX Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of PHGE stock worth $100,000 on 28 July 2021.
The largest trade he's ever made was buying 25,000 units of BiomX Inc stock on 28 July 2021 worth over $100,000. On average, Jonathan trades about 2,778 units every 0 days since 2020. As of 28 July 2021 he still owns at least 25,000 units of BiomX Inc stock.
You can see the complete history of Mr. Solomon stock trades at the bottom of the page.
Jonathan Eitan Solomon serves as Chief Executive Officer, Director of the Company. Mr. Solomon has served as the Chief Executive Officer and as a director of the Company since October 2019. Mr. Solomon served as Chief Executive Officer of BiomX Israel from May 2017 to October 2019. From July 2007 to December 2015, Mr. Solomon was a co-founder, President, and Chief Executive Officer of ProClara Biosciences Inc. (formerly NeuroPhage Pharmaceuticals Inc.), a biotechnology company pioneering an approach to treating neurodegenerative diseases. Prior to joining ProClara, he served for ten years in a classified military unit of the Israeli Defense Forces. Mr. Solomon holds a B.Sc. magna cum laude in Physics and Mathematics from the Hebrew University, an M.Sc. summa cum laude in Electrical Engineering from Tel Aviv University, and an M.B.A. with honors from the Harvard Business School.
As the Chief Executive Officer a Director of BiomX Inc, the total compensation of Jonathan Solomon at BiomX Inc is $936,565. There are no executives at BiomX Inc getting paid more.
Jonathan Solomon is 43, he's been the Chief Executive Officer a Director of BiomX Inc since 2019. There are 11 older and 2 younger executives at BiomX Inc. The oldest executive at BiomX Inc is Alan Moses, 72, who is the Independent Director.
Jonathan's mailing address filed with the SEC is C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4, , NESS ZIONA,, L3, 7414003.
Over the last 5 years, insiders at BiomX Inc have traded over $332,366 worth of BiomX Inc stock and bought 1,036,414 units worth $787,614 . The most active insiders traders include James Edeerfield Management..., Chidozie Ugwumba a Erez Chimovits. On average, BiomX Inc executives and independent directors trade stock every 68 days with the average trade being worth of $533,749. The most recent stock trade was executed by James Edeerfield Management... on 15 July 2024, trading 11,766,000 units of PHGE stock currently worth $11,648,340.
biomx is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (ibd) and cancer. we discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. the company’s platforms use computational and synthetic biology and cutting-edge research from profs. rotem sorek, ph.d., eran elinav, m.d., ph.d., and eran segal, ph.d., of the weizmann institute of science; and professor timothy k. lu, m.d., ph.d., of the massachusetts institute of technology. investors in the company include orbimed israel incubator lp, johnson & johnson development corporation inc., takeda ventures, inc., seventure partners, mirae asset global investments, and sbi.
BiomX Inc executives and other stock owners filed with the SEC include: